Regulatory and Reimbursement Innovation

Regulatory and reimbursement innovation.

Coverage with evidence development and parallel review for molecular diagnostics aid regulation and reimbursement.

Paying for innovation: reimbursement incentives for antibiotics.

Regulatory Reform and Innovation

2 3 FOREWORD Government regulations can have both positive and negative effects on the innovation process. Among other goals, regulatory reform in the OECD countries is intended to enhance the positive regulatory effects on innovation. Reforms should help ensure that regulations in all spheres of activity are fully responsive to changes in the economic, social and technical conditions surroundi...

Analysis of the Regulatory and Reimbursement landscape of Biosimilars

INTRODUCTION A biosimilar is a biological medicine that is developed to be similar to an existing biologic, with the active component of the biosimilar being essentially the same biological substance as its reference product. A wide variety of biosimilars are available, from relatively small molecules such as human insulin or erythropoietin, to complex molecules such as monoclonal antibodies. B...

Innovation Ranking in France and Italy: Differences and their Impact on Pricing and Reimbursement Processes.

& Reimbursement All analyses and interpretations of the data are solely those of the authors and do not refl ect the positions or policies of PHMR Ltd. Contact: Mark Ratcliffe, Managing Director, PHMR Ltd., Berkeley Works, Berkley Grove, London, United Kingdom NW1 8XY Offi ce Tel: +44 (0)2036 955 800. E-mail: [email protected]. • To investigate differences between therapeutic innovation cr...